Rey R, Grinspon R
Front Endocrinol (Lausanne). 2024; 15:1361032.
PMID: 38501100
PMC: 10944898.
DOI: 10.3389/fendo.2024.1361032.
Josso N, Rey R
Front Endocrinol (Lausanne). 2020; 11:619.
PMID: 33013698
PMC: 7506080.
DOI: 10.3389/fendo.2020.00619.
Umer S, Zhao S, Sammad A, Sahlu B, Yunwei P, Zhu H
Genes (Basel). 2019; 10(12).
PMID: 31817280
PMC: 6947652.
DOI: 10.3390/genes10121009.
Kim J, MacLaughlin D, Donahoe P
Obstet Gynecol Sci. 2014; 57(5):343-57.
PMID: 25264524
PMC: 4175594.
DOI: 10.5468/ogs.2014.57.5.343.
Mullen R, Behringer R
Sex Dev. 2014; 8(5):281-96.
PMID: 25033758
PMC: 4378544.
DOI: 10.1159/000364935.
Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.
Park J, Tanaka Y, Arango N, Zhang L, Benedict L, Roh M
Dev Biol. 2013; 386(1):227-36.
PMID: 24362065
PMC: 4047716.
DOI: 10.1016/j.ydbio.2013.12.015.
Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.
Song J, Jo H, Kim M, Lew Y, Ryu K, Cha J
Int J Oncol. 2012; 40(6):2013-21.
PMID: 22344630
PMC: 5609185.
DOI: 10.3892/ijo.2012.1370.
β-Catenin is essential for Müllerian duct regression during male sexual differentiation.
Kobayashi A, Stewart C, Wang Y, Fujioka K, Thomas N, Jamin S
Development. 2011; 138(10):1967-75.
PMID: 21490063
PMC: 3082302.
DOI: 10.1242/dev.056143.
Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme.
Tanwar P, Zhang L, Tanaka Y, Taketo M, Donahoe P, Teixeira J
Proc Natl Acad Sci U S A. 2010; 107(37):16142-7.
PMID: 20805501
PMC: 2941287.
DOI: 10.1073/pnas.1011606107.
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.
MacLaughlin D, Donahoe P
Future Oncol. 2010; 6(3):391-405.
PMID: 20222796
PMC: 3935316.
DOI: 10.2217/fon.09.172.
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct.
Fujino A, Arango N, Zhan Y, Manganaro T, Li X, MacLaughlin D
Dev Biol. 2008; 325(2):351-62.
PMID: 19013450
PMC: 3935311.
DOI: 10.1016/j.ydbio.2008.10.027.
The persistent müllerian duct syndrome: a rare cause of cryptorchidism.
Josso N, Picard J, Imbeaud S, Carre-Eusebe D, Zeller J, Adamsbaum C
Eur J Pediatr. 1993; 152 Suppl 2:S76-8.
PMID: 8101816
DOI: 10.1007/BF02125444.
Molecular differentiation of the mouse genital tract: serum-free organ culture system for morphological and biochemical correlations.
Newbold R, CARTER D, Harris S, McLachlan J
In Vitro. 1981; 17(1):51-4.
PMID: 7216239
DOI: 10.1007/BF02618030.
Anti-Müllerian hormone: a local or long-distance morphogenetic factor?.
Vigier B, Picard J, BEZARD J, Josso N
Hum Genet. 1981; 58(1):85-90.
PMID: 6895208
DOI: 10.1007/BF00284154.
Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice.
Donahoe P, Fuller Jr A, Scully R, Guy S, Budzik G
Ann Surg. 1981; 194(4):472-80.
PMID: 6895157
PMC: 1345325.
DOI: 10.1097/00000658-198110000-00010.
Dissociation between testicular organogenesis and endocrine cytodifferentiation of Sertoli cells.
Magre S, Jost A
Proc Natl Acad Sci U S A. 1984; 81(24):7831-4.
PMID: 6595663
PMC: 392246.
DOI: 10.1073/pnas.81.24.7831.
Experimental control of the differentiation of Leydig cells in the rat fetal testis.
Jost A, Perlman S, Valentino O, Castanier M, Scholler R, Magre S
Proc Natl Acad Sci U S A. 1988; 85(21):8094-7.
PMID: 3186712
PMC: 282361.
DOI: 10.1073/pnas.85.21.8094.
Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries.
Vigier B, Forest M, Eychenne B, BEZARD J, Garrigou O, Robel P
Proc Natl Acad Sci U S A. 1989; 86(10):3684-8.
PMID: 2726747
PMC: 287204.
DOI: 10.1073/pnas.86.10.3684.
